54070-74-5 Usage
Uses
Used in Pharmaceutical Industry:
Cyclopropanecarboxamidine is utilized as a key intermediate in the synthesis of various pharmaceutical compounds. Its unique reactivity allows for the creation of complex organic molecules that can be used in the development of new drugs with improved efficacy and selectivity.
Used in Agrochemical Industry:
In the agrochemical sector, Cyclopropanecarboxamidine serves as a vital component in the synthesis of agrochemicals. Its ability to undergo various chemical transformations enables the production of compounds with specific pesticidal or herbicidal properties, contributing to more effective crop protection.
Used in Organic Synthesis:
Cyclopropanecarboxamidine is employed as a versatile reagent in organic synthesis for the preparation of a broad spectrum of organic compounds. Its distinct cyclopropane structure and high reactivity make it an essential building block for the synthesis of complex organic molecules with potential applications in various fields.
Used in Development of New Synthetic Methods:
CP-Carbamidine is used as a catalyst or reactant in the development of innovative synthetic methods and strategies. Its unique reactivity allows for the exploration of new pathways and mechanisms in chemical reactions, leading to more efficient and selective synthetic processes.
Check Digit Verification of cas no
The CAS Registry Mumber 54070-74-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,4,0,7 and 0 respectively; the second part has 2 digits, 7 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 54070-74:
(7*5)+(6*4)+(5*0)+(4*7)+(3*0)+(2*7)+(1*4)=105
105 % 10 = 5
So 54070-74-5 is a valid CAS Registry Number.
54070-74-5Relevant academic research and scientific papers
CHEMICAL COMPOUNDS WITH DUAL ACTIVITY, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS
-
Page/Page column 30, (2008/06/13)
The present invention concerns chemical compounds combining affinity and antagonism against the human m3 muscarinic receptor with activity as selective phosphodiesterase IV (PDE IV) inhibitors, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
